{"type":"profile","id":"profile=medica2026.3081331","exhSeoId":"anw7zuuwTqqXUFIKTLTE9w","name":"CER Groupe FUP","email":"f.cote@cergroupe.be","getInTouchEmail":"f.cote@cergroupe.be","profileAddress":{"address":["Rue de la Science 8"],"city":"Aye","zip":"6900","country":"Belgium","countryCode":"BE"},"phone":{"phone":"+32 84 220211"},"links":[{"id":"link=ZXYfLMGIRKezjbQiyrw3Ow","type":"link","link":"https://www.cergroupe.be","parentType":"profile","order":1,"visibleInLang":["en","de"]}],"media":[],"locations":[{"areaId":"01","area":"Hall 1","stand":"G56"}],"location":"Hall 1 / G56","locationIsVirtual":false,"events":[{"key":"medica2026","label":"MEDICA 2026"}],"eventIcons":[{"label":"MEDICA 2026","src":"https://www.medica.de/vis-content/event-medica2026/all-exh/Event-0mOSbpheSRej6t2ZLcI1AA.png"}],"eventMap":"https://iahapla02.messe-duesseldorf.de/en/2dexgroundV2/medica2026/3081331.svg","areaMap":"https://iahapla02.messe-duesseldorf.de/en/3dhallV2/medica2026/01/3081331.svg","areaId":"01","mainExhibitor":{"id":"medica2026.3072721","label":"Wallonia Export and Investment Agency (AWEX)","exhSeoId":"ZGGExyGoT62oMx7XMwbyKA"},"premium":false,"exhIsLead":false,"logoUploadedByPubimport":false,"tags":[],"xtags":[],"socialMedia":[],"synonyms":[],"text":"<p>CER Groupe is a Research Center recognized for its integrated expertise serving the diagnostic industry. We support our partners in the <strong>development, qualification, and secured supply of proprietary critical raw materials portfolio.</strong></p><p><br></p><p>Through advanced platforms combining biotechnology, immunology, bioconjugation and analytics, we help transform ideas into <strong>robust, reliable, and compliant diagnostic solutions</strong>. </p><p><br></p><p>Our strength lies in a comprehensive and agile scientific approach, bridging <strong>molecular design, biological production, advanced characterization, and functional validation within a single site</strong>. </p><p><br></p><p>From antibody and antigen development to conjugation and stabilization process mastery, CER Groupe acts as a strategic partner to strengthen the performance, continuity, and sovereignty of supply chains in the in vitro diagnostics industry.</p><p><br></p><p><strong>Critical Raw Materials Development &#38; Production</strong></p><ul><li>Antibody discovery and production</li><li>Antigen design &#38; production (haptens, conjugates, peptides, proteins, cell lines, DNA)</li><li>12 species for polyclonal antibody large scale production</li><li>Monoclonal antibodies from mouse, rat, rabbit &#38; llama nanobodies</li><li>DNA immunization hybridoma and B cell sequencing technologies</li><li>Antibody engineering (chimerization, antibody fragments)</li><li>Recombinant proteins and antibodies: in E.coli and proprietary high-producing mammalian cells platforms</li><li>Conjugation technologies from stochastic to proprietary regioselective technologies (with enzymes, fluorescents dyes, beads,...)</li><li>Upstream/Dowstream process development and optimization (bioreactor, FPLC, TFF, freeze-drying)</li><li>Native bioproducts extraction: proteins, lipids, tissues, ...</li></ul><p><strong>Molecular characterization</strong></p><ul><li>Product characterization: affinity, cross-reactivity, developability, integrity, stability</li><li>Antibody sequencing (VH/VL, full antibody sequencing, de novo sequencing)</li><li>Advanced product quality profiling: N-glycans, N-term variability, impurities, intact mass, peptide mapping</li><li>Conjugate characterization: degree of labelling (DOL) and distribution, residual immuno-reactive fraction (IRF)</li><li>Analytical platforms for customized assays: molecular biology, FACS, immunoassays, cell-based assays, mass spectrometry, molecular interaction</li></ul><p><strong>Product/Assay Development</strong></p><ul><li>Assay prototyping: reagent selection, match-pairing studies</li><li>Advanced functionalization strategies (surface, microfluidic, beads...)</li><li>Freeze-drying: process development &#38; routine manufacturing</li><li>Quality control &#38; stability testing</li><li>Validation with human body material samples (biobank certification)</li><li><em>In vivo</em> imaging systems for medical diagnostic product development</li></ul><p><strong>Business Continuity Assurance</strong></p><ul><li>Biomarker portfolio management and back-up supply</li><li>Long-term secured cryostorage &#38; biobanking for human body material (-80°C and gaseous N₂)</li><li>Monoclonal antibody sequencing from hybridoma or purified product</li></ul><p><br></p>","pdfs":[],"tol":[],"categories":[{"id":"prod=medica2026.01.02.01","label":"Clinical chemistry & immunoassays","catalogIndex":"01.02.01","eventIcons":[{"key":"medica2026","small":"https://www.medica.de/vis-content/event-medica2026/all-exh/Event-SzHinHZFRDix2fwVNyP4ag.png","tiny":"https://www.medica.de/vis-content/event-medica2026/all-exh/Event-0mOSbpheSRej6t2ZLcI1AA.png","label":"MEDICA 2026"}],"productList":[{"id":"prodinfo=ujtMmME4R92ULGxN8QiAdw","label":"Bioproduction - Customized antibodies"},{"id":"prodinfo=TqBAM2iCRTWnIKYhfxAZ5A","label":"Non-clinical services - Immunomonitoring"},{"id":"prodinfo=LdFFsZEPQ6WEBBSH5QUcfw","label":"Tests for food and animal feed"}],"hierarchy":[{"id":"01","label":"Clinical Diagnostics & Therapeutic Technologies"},{"id":"01.02","label":"Laboratory, IVD & Diagnostics"},{"id":"01.02.01","label":"Clinical chemistry & immunoassays"}]}],"write":false,"lastModified":"2026-11-03T21:47:30Z","tagsAreEditable":false,"xtagsAreEditable":false,"isGetInTouchAllowed":false}